Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: Development of recommendations for clinical practice based on published evidence and expert opinion
Authors:
- Stephan PavySPStephan Pavy
- Emmanuelle DernisEDEmmanuelle Dernis
- Philippe GoupillePGPhilippe Goupille
- Alain CantagrelACAlain Cantagrel
- Jacques TebibJTJacques Tebib
- Pascal ClaudepierrePCPascal Claudepierre
- René Marc FlipoRFRené Marc Flipo
- Xavier Le LoëtXLXavier Le Loët
- Jean-Francis MaillefertJMJean-Francis Maillefert
- Xavier MarietteXMXavier Mariette
- Alain SarauxASAlain Saraux
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Joint Bone Spine
- Vol. 74 (4) , 346-352
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: Development of recommendations for clinical practice based on published evidence and expert opinionJoint Bone Spine, 2007
- Imaging for the diagnosis and follow-up of ankylosing spondylitis: Development of recommendations for clinical practice based on published evidence and expert opinionJoint Bone Spine, 2007
- Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritisAnnals of the Rheumatic Diseases, 2005
- Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinionJoint Bone Spine, 2005
- Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drugArthritis & Rheumatism, 2001
- Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trialRheumatology, 1999
- Clinical guidelines: Developing guidelinesBMJ, 1999
- Ximoprofen in Ankylosing Spondylitis:A Double Blind Placebo Controlled Dose Ranging StudyScandinavian Journal of Rheumatology, 1994
- Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.Annals of the Rheumatic Diseases, 1974
- AZAPROPAZONE IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: A CONTROLLED CLINICAL TRIALRheumatology, 1974